Ascendia
Peter Meehan is a Senior Scientist at Ascendia Pharmaceuticals, with extensive experience in analytical method development and validation for various drug formulations. Previously, Peter held roles at InnoPharma, Inc. as a Scientist, Enzon Pharmaceuticals as a Research Associate and Senior QC Analyst, Johnson & Johnson Consumer Products as an Analyst, and Able Laboratories in various capacities, including Quality Control Chemist and Coordinator of Document Control and Stability Administration. Through these roles, Peter has developed analytical methods, performed stability testing, and contributed to regulatory compliance in both cGMP and GLP environments. Peter holds a Bachelor’s degree in Chemistry from Cornell University.
This person is not in any offices
Ascendia
1 followers
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates. It specializes in improving the solubility and bioavailability of poorly water-soluble drugs using its suite of nanotechnology platforms. Ascendia formulates products for injectable, oral, and topical routes ofadministration. The company has three technology platforms - EmulSol for producing nano-emulsions, AmorSol for creating amorphous solid dispersions, and NanoSol for formulating nano-particles.